Document is current
Any future updates will be listed below
-
Authors
Tsou, Amy M. https://orcid.org/0000-0002-0222-5057
Goettel, Jeremy A.
Bao, Bin
Biswas, Amlan
Kang, Yu Hui
Redhu, Naresh S.
Peng, Kaiyue
Putzel, Gregory G.
Saltzman, Jeffrey
Kelly, Ryan
Gringauz, Jordan
Barends, Jared
Hatazaki, Mai
Frei, Sandra M.
Emani, Rohini
Huang, Ying
Shen, Zeli
Fox, James G.
Glickman, Jonathan N.
Horwitz, Bruce H.
Snapper, Scott B.
-
Funding
Funding for this research was provided by:
Crohn's and Colitis Foundation (527125, 352644)
Boston Children's Hospital Fred Lovejoy House-Staff Research and Education Award
National Institutes of Health (P30DK034854, DK106311)
Leona M. and Harry B. Helmsley Charitable Trust
Wolpow Family Chair in IBD Treatment and Research
Boston Children's Hospital Translational Investigator Service
- License Information
-
More Information
Article History
Received: 18 May 2021
Accepted: 10 September 2021
First Online: 3 November 2021
Declarations
:
: This study was approved by the Boston Children’s Hospital (BCH) Institutional Animal Care and Use Committee and the subcommittee on Research Animal Care at Massachusetts General Hospital (MGH). The review was conducted in accordance with the standards outlined in the National Research Council’s Guide for the Care and Use of Laboratory Animals and BCH’s Animal Welfare Assurance.
: Not applicable
: S.B.S. is supported by grants or in-kind contributions from Pfizer, Novartis, Takeda, and Regeneron. He is on the scientific advisory boards of Pfizer, Janssen, IFM Therapeutics, Merck, Lycera, Inc., Celgene, Lilly, Pandion Therapeutics, and Applied Molecular Transport. He has consulted for Amgen, Hoffman La-Roche.
